• Located in separate lidded container in dispensing cabinet. • Labeled MAGNESIUM SULFATE 50% (CONCENTRATED) in large red lettering.
High Alert Drug: magnesium sulfate IV
• Pre-mixed IV solution • Policy for monitoring requirements in relation to dosing
Per policy, these medications require cardiac and/or special monitoring. (KEY: "Y" = may be given as described on chart. "N" = may NOT be given except in Rapid Response/Code Blue situations or as otherwise described in Exceptions section of Policy.
generic (Brand) / Notes
CCU, OR, PACU, CCL, ED
PCU
2N (Tele)
1N (Tele), 3N (Tele)
Med/Surg (1N w/o Tele, 3N w/o Tele, 4N, 5N)
BirthPlace
SNF
ICS
OPS
magnesium sulfate IVPB, IV infusion
Y (≤ 4 gm)
Y (≤ 4 gm, ≤ 2 gm/hr)
Y (≤ 4 gm, ≤ 2 gm/hr)
Y (≤ 4 gm, ≤ 2 gm/hr)
Y (≤ 4 gm, ≤ 2 gm/hr)
Y (IVPB ≤ 6 gm)
Y (IVPB ≤ 1 gm)
Y (≤ 4 gm, ≤ 2 gm/hr)
Y (≤ 4 gm, ≤ 2 gm/hr)
Per policy, orders for these non-formulary agents will be changed to formulary equivalents.
Non-Formulary Agent
Formulary Equivalent
magnesium oral supplements
magnesium oxide (Mag-Ox) dose adjust down to nearest tablet size (nearest 400 mg)
• Labeled MAGNESIUM SULFATE 50% (CONCENTRATED) in large red lettering.
• Policy for monitoring requirements in relation to dosing
(KEY: "Y" = may be given as described on chart. "N" = may NOT be given except in Rapid Response/Code Blue situations or as otherwise described in Exceptions section of Policy.
IVPB, IV infusion
(≤ 4 gm)
(≤ 4 gm,
≤ 2 gm/hr)
(≤ 4 gm,
≤ 2 gm/hr)
(≤ 4 gm,
≤ 2 gm/hr)
(≤ 4 gm,
≤ 2 gm/hr)
(IVPB ≤ 6 gm)
(IVPB ≤ 1 gm)
(≤ 4 gm,
≤ 2 gm/hr)
(≤ 4 gm,
≤ 2 gm/hr)